Combination of novel HER2‐targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2‐positive gastric cancer

The synergistic interaction of two antibodies targeting the same protein could be developed as an effective anti‐cancer therapy. Human epidermal growth factor receptor 2 (HER2) is overexpressed in 20–25% of breast and gastric cancer patients, and HER2‐targeted antibody therapy using trastuzumab is e...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Oncol
Päätekijät: Ko, Bong-Kook, Lee, Sook-Yeon, Lee, Young-Ha, Hwang, In-Sik, Persson, Helena, Rockberg, Johan, Borrebaeck, Carl, Park, Dongeun, Kim, Kyu-Tae, Uhlen, Mathias, Lee, Jong-Seo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2014
Aiheet:
Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528653/
https://ncbi.nlm.nih.gov/pubmed/25306393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.09.007
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia